Synthesis, biological evaluation, and in silico studies of new CDK2 inhibitors based on pyrazolo[3,4- d ]pyrimidine and pyrazolo[4,3- e ][1,2,4]triazolo[1,5- c ]pyrimidine scaffold with apoptotic activity

Asmaa A. Mandour, Ibrahim F. Nassar, Mohammed Taha Abdel Aal, Mahmoud Ahmed Shahin, Wael A. El‐Sayed, Maghawry Hegazy, Amr Mohamed Yehia, Ahmed Ismail, Mohamed Hagras, Eslam B. Elkaeed, Hanan M. Refaat, Nasser S. M. Ismail

2022Journal of Enzyme Inhibition and Medicinal Chemistry42 citationsDOI Open Access PDF

Abstract

ADMET studies and drug-likeness showed proper pharmacokinetic properties which helped in structure requirements prediction for the observed antitumor activity.

Topics & Concepts

Cyclin-dependent kinase 2PyrimidineChemistryDocking (animal)CytotoxicityCell cycleIn silicoStereochemistryIC50BiochemistryCyclin-dependent kinaseApoptosisIn vitroNursingMedicineGeneCancer Mechanisms and TherapyCancer-related Molecular PathwaysCancer therapeutics and mechanisms

Synthesis, biological evaluation, and <i>in silico</i> studies of new CDK2 inhibitors based on pyrazolo[3,4- <i>d</i> ]pyrimidine and pyrazolo[4,3- <i>e</i> ][1,2,4]triazolo[1,5- <i>c</i> ]pyrimidine scaffold with apoptotic activity

Abstract

Topics & Concepts